Cargando…
CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells
AIMS: Poor efficacy of chemotherapy drugs in non-small-cell lung cancer (NSCLC) is the key reason for the failure of treatment, but the mechanism of this remains largely unknown. Stromal cell-derived factor 1-alpha (SDF-1α/CXCL12) is a small chemotactic cytokine protein that plays an important role...
Autores principales: | Wang, Meng, Lin, Tie, Wang, Yicun, Gao, Song, Yang, Zhaoyang, Hong, Xuan, Chen, Gongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499863/ https://www.ncbi.nlm.nih.gov/pubmed/28721072 http://dx.doi.org/10.2147/OTT.S133055 |
Ejemplares similares
-
Delamanid suppresses CXCL10 expression via regulation of JAK/STAT1 signaling and correlates with reduced inflammation in tuberculosis patients
por: Qiao, Min, et al.
Publicado: (2022) -
Ginkgetin induces apoptosis in 786-O cell line via suppression of JAK2-STAT3 pathway
por: Ren, Yu, et al.
Publicado: (2016) -
Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway
por: Malemud, Charles J.
Publicado: (2010) -
Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway
por: Liu, Jiafei, et al.
Publicado: (2019) -
CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
por: Sun, Meng-Yao, et al.
Publicado: (2019)